StockWatch
·

MANGALAM DRUGS & ORGANICS LTD. Q4 FY25 Results

MANGALAMQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue73.0417.7%
Total Income73.2517.6%
Expenditure71.6118.1%
PBT1.6319.6%
Net Profit0.0695.4%
OPM13.91%21.02pp
NPM0.08%1.37pp
EPS0.0495.1%
View full financials

Informational and educational content only. Not investment advice.